Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
26.35
-0.49 (-1.83%)
Nov 3, 2025, 4:00 PM EST - Market closed
Fresenius Medical Care AG Revenue
Fresenius Medical Care AG had revenue of 4.79B EUR in the quarter ending June 30, 2025, with 0.53% growth. This brings the company's revenue in the last twelve months to 19.52B, up 0.53% year-over-year. In the year 2024, Fresenius Medical Care AG had annual revenue of 19.34B, down -0.61%.
Revenue (ttm)
19.52B EUR
Revenue Growth
+0.53%
P/S Ratio
0.67
Revenue / Employee
175,030 EUR
Employees
111,513
Market Cap
15.24B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19.34B | -117.71M | -0.61% |
| Dec 31, 2023 | 19.45B | 55.60M | 0.29% |
| Dec 31, 2022 | 19.40B | 1.78B | 10.10% |
| Dec 31, 2021 | 17.62B | -240.38M | -1.35% |
| Dec 31, 2020 | 17.86B | 382.51M | 2.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 56.50B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.11B |
FMS News
- 4 days ago - Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025 - PRNewsWire
- 4 weeks ago - Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement - PRNewsWire
- 6 weeks ago - Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment - PRNewsWire
- 3 months ago - Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework - PRNewsWire
- 3 months ago - Fresenius Medical Care AG (FMS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025 - PRNewsWire
- 3 months ago - Fresenius Medical Care: Is Trading Below Its Intrinsic Value (Buy) - Seeking Alpha
- 3 months ago - $6.3 Trillion Outpatient Clinics Markets, 2021-2024 & 2025-2029 | Profiles of Leading Players - Johns Hopkins Medicine, Mayo Clinic, MD Anderson Cancer Center, Apollo Hospital, and Fresenius Medical - GlobeNewsWire